Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ana Gorostidi

Showing results (1-10 of 43) with videos related to

Pageof 5
Sort By:
Genetics|February 22, 2015
Beyond asexual development: modifications in the gene expression profile caused by the absence of the Aspergillus nidulans transcription factor FlbBElixabet Oiartzabal-Arano, Aitor Garzia, Ana Gorostidi, et al.
Frontiers in Aging Neuroscience|August 1, 2014
Epitope Mapping of Antibodies to Alpha-Synuclein in LRRK2 Mutation Carriers, Idiopathic Parkinson Disease Patients, and Healthy ControlsBeatriz Alvarez-Castelao, Ana Gorostidi, Javier Ruíz-Martínez, et al.
Journal of Human Genetics|July 3, 2015
GIGYF2 mutation in late-onset Parkinson's disease with cognitive impairmentJavier Ruiz-Martinez, Catharine E Krebs, Vladimir Makarov, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|November 13, 2009
Identification of a novel THAP1 mutation at R29 amino-acid residue in sporadic patients with early-onset dystoniaCoro Paisán-Ruiz, Javier Ruiz-Martinez, Marta Ruibal, et al.
Molecular Diagnosis & Therapy|June 14, 2016
Genetic Mutation Analysis of Parkinson's Disease Patients Using Multigene Next-Generation Sequencing PanelsAna Gorostidi, José Félix Martí-Massó, Alberto Bergareche, et al.
International Journal of Dermatology|January 7, 2026
Molecular Changes Induced by Carbon Dioxide Laser in Hailey-Hailey Disease: A Potential Mechanism Underlying Treatment EfficacyJavier Antoñanzas, Agustín España, Ana Gorostidi, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|September 8, 2009
Neuropathology of Parkinson's disease with the R1441G mutation in LRRK2José-Félix Martí-Massó, Javier Ruiz-Martínez, Maria J Bolaño, et al.
Aging|April 28, 2017
Progressive changes in non-coding RNA profile in leucocytes with ageMaider Muñoz-Culla, Haritz Irizar, Ana Gorostidi, et al.
Frontiers in Neurology|March 25, 2021
A More Homogeneous Phenotype in Parkinson's Disease Related to R1441G Mutation in the LRRK2 GeneAna Vinagre-Aragón, David Campo-Caballero, Elisabet Mondragón-Rezola, et al.
Neurobiology of Aging|December 24, 2013
Leucine-rich repeat kinase 2 modulates cyclooxygenase 2 and the inflammatory response in idiopathic and genetic Parkinson's diseaseRakel Lopez de Maturana, Julio C Aguila, Amaya Sousa, et al.
Pageof 5

Showing results (1-10 of 43) with videos related to

Sort By:
Pageof 5
Genetics|February 22, 2015
Beyond asexual development: modifications in the gene expression profile caused by the absence of the Aspergillus nidulans transcription factor FlbBElixabet Oiartzabal-Arano, Aitor Garzia, Ana Gorostidi, et al.
Frontiers in Aging Neuroscience|August 1, 2014
Epitope Mapping of Antibodies to Alpha-Synuclein in LRRK2 Mutation Carriers, Idiopathic Parkinson Disease Patients, and Healthy ControlsBeatriz Alvarez-Castelao, Ana Gorostidi, Javier Ruíz-Martínez, et al.
Journal of Human Genetics|July 3, 2015
GIGYF2 mutation in late-onset Parkinson's disease with cognitive impairmentJavier Ruiz-Martinez, Catharine E Krebs, Vladimir Makarov, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|November 13, 2009
Identification of a novel THAP1 mutation at R29 amino-acid residue in sporadic patients with early-onset dystoniaCoro Paisán-Ruiz, Javier Ruiz-Martinez, Marta Ruibal, et al.
Molecular Diagnosis & Therapy|June 14, 2016
Genetic Mutation Analysis of Parkinson's Disease Patients Using Multigene Next-Generation Sequencing PanelsAna Gorostidi, José Félix Martí-Massó, Alberto Bergareche, et al.
International Journal of Dermatology|January 7, 2026
Molecular Changes Induced by Carbon Dioxide Laser in Hailey-Hailey Disease: A Potential Mechanism Underlying Treatment EfficacyJavier Antoñanzas, Agustín España, Ana Gorostidi, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|September 8, 2009
Neuropathology of Parkinson's disease with the R1441G mutation in LRRK2José-Félix Martí-Massó, Javier Ruiz-Martínez, Maria J Bolaño, et al.
Aging|April 28, 2017
Progressive changes in non-coding RNA profile in leucocytes with ageMaider Muñoz-Culla, Haritz Irizar, Ana Gorostidi, et al.
Frontiers in Neurology|March 25, 2021
A More Homogeneous Phenotype in Parkinson's Disease Related to R1441G Mutation in the LRRK2 GeneAna Vinagre-Aragón, David Campo-Caballero, Elisabet Mondragón-Rezola, et al.
Neurobiology of Aging|December 24, 2013
Leucine-rich repeat kinase 2 modulates cyclooxygenase 2 and the inflammatory response in idiopathic and genetic Parkinson's diseaseRakel Lopez de Maturana, Julio C Aguila, Amaya Sousa, et al.
Pageof 5